These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11845814)

  • 1. Muscle strength and tibolone: a randomised, double-blind, placebo-controlled trial.
    Meeuwsen IB; Samson MM; Duursma SA; Verhaar HJ
    BJOG; 2002 Jan; 109(1):77-84. PubMed ID: 11845814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postmenopausal HRT and tibolone in relation to muscle strength and body composition.
    Jacobsen DE; Samson MM; Kezic S; Verhaar HJ
    Maturitas; 2007 Sep; 58(1):7-18. PubMed ID: 17576043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of tibolone in older postmenopausal women.
    Cummings SR; Ettinger B; Delmas PD; Kenemans P; Stathopoulos V; Verweij P; Mol-Arts M; Kloosterboer L; Mosca L; Christiansen C; Bilezikian J; Kerzberg EM; Johnson S; Zanchetta J; Grobbee DE; Seifert W; Eastell R;
    N Engl J Med; 2008 Aug; 359(7):697-708. PubMed ID: 18703472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Raloxifene and tibolone in elderly women: a randomized, double-blind, double-dummy, placebo-controlled trial.
    Jacobsen DE; Melis RJ; Verhaar HJ; Olde Rikkert MG
    J Am Med Dir Assoc; 2012 Feb; 13(2):189.e1-7. PubMed ID: 21741883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tibolone does not affect muscle power and functional ability in healthy postmenopausal women.
    Meeuwsen IB; Samson MM; Duursma SA; Verhaar HJ
    Clin Sci (Lond); 2002 Feb; 102(2):135-41. PubMed ID: 11834133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, placebo-controlled, crossover study of tibolone (Livial) on menopause symptoms, psychological well-being, and dyadic relationship of postmenopausal Chinese women and their spouses.
    Lam PM; Cheung GW; Shek DT; Lee DT; Haines CJ; Chung TK
    Menopause; 2004; 11(4):416-22. PubMed ID: 15243279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short and long term effects of tibolone in postmenopausal women.
    Formoso G; Perrone E; Maltoni S; Balduzzi S; D'Amico R; Bassi C; Basevi V; Marata AM; Magrini N; Maestri E
    Cochrane Database Syst Rev; 2012 Feb; (2):CD008536. PubMed ID: 22336846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of tibolone in postmenopausal women receiving tamoxifen after surgery for breast cancer: a randomised, double-blind, placebo-controlled trial.
    Kroiss R; Fentiman IS; Helmond FA; Rymer J; Foidart JM; Bundred N; Mol-Arts M; Kubista E
    BJOG; 2005 Feb; 112(2):228-33. PubMed ID: 15663589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tibolone improves depression in women through the menopause transition: A double-blind randomized controlled trial of adjunctive tibolone.
    Kulkarni J; Gavrilidis E; Thomas N; Hudaib AR; Worsley R; Thew C; Bleeker C; Gurvich C
    J Affect Disord; 2018 Aug; 236():88-92. PubMed ID: 29723767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of tibolone on climacteric symptoms and quality of life in breast cancer patients--data from LIBERATE trial.
    Sismondi P; Kimmig R; Kubista E; Biglia N; Egberts J; Mulder R; Planellas J; Moggio G; Mol-Arts M; Kenemans P
    Maturitas; 2011 Dec; 70(4):365-72. PubMed ID: 22030384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of tibolone on quality of life in postmenopausal women.
    Meeuwsen IB; Samson MM; Duursma SA; Verhaar HJ
    Maturitas; 2002 Jan; 41(1):35-43. PubMed ID: 11809341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of tibolone on abdominal subcutaneous fat, serum leptin levels, and anthropometric indices: a 6-month, prospective, randomized, placebo-controlled, double-blind study.
    Odabasi AR; Yuksel H; Kafkas S; Demircan S; Karul A; Kozaci D; Koseoglu K; Onur E
    Adv Ther; 2006; 23(6):926-37. PubMed ID: 17276962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of tibolone and menopausal transition: a randomized, double-blind placebo-controlled trial.
    Morais-Socorro M; Cavalcanti MA; Martins R; Neto Francisco P; Rezende A; Azevedo G; Almeida M
    Gynecol Endocrinol; 2012 Jun; 28(6):483-7. PubMed ID: 22132809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a continuous-combined regimen of low-dose hormone therapy (oestradiol and norethindrone acetate) and tibolone on the quality of life in symptomatic postmenopausal women: a double-blind, randomised study.
    Polisseni AF; Andrade AT; Ribeiro LC; Castro IQ; Brandão M; Polisseni F; Guerra Mde O
    Maturitas; 2013 Feb; 74(2):172-8. PubMed ID: 23201326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of tibolone on fat mass, fat-free mass, and total body water in postmenopausal women.
    Meeuwsen IB; Samson MM; Duursma SA; Verhaar HJ
    Endocrinology; 2001 Nov; 142(11):4813-7. PubMed ID: 11606448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of tibolone and continuous combined conjugated equine estrogen/medroxyprogesterone acetate on the endometrium and vaginal bleeding: results of the OPAL study.
    Langer RD; Landgren BM; Rymer J; Helmond FA;
    Am J Obstet Gynecol; 2006 Nov; 195(5):1320-7. PubMed ID: 16875644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormone replacement therapy with tibolone: effects on sexual functioning in postmenopausal women.
    Egarter C; Topcuoglu A; Vogl S; Sator M
    Acta Obstet Gynecol Scand; 2002 Jul; 81(7):649-53. PubMed ID: 12190840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular resistance of central retinal and ophthalmic arteries in postmenopausal women after use of tibolone.
    de Souza MA; de Souza BM; Geber S
    Menopause; 2012 Mar; 19(3):328-31. PubMed ID: 22042323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of oral tibolone 1.25 or 2.5 mg/day vs. placebo in postmenopausal women.
    Hudita D; Posea C; Ceausu I; Rusu M
    Eur Rev Med Pharmacol Sci; 2003; 7(5):117-25. PubMed ID: 15214586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tibolone in postmenopausal women with systemic lupus erythematosus: a pilot study.
    Vieira CS; Pereira FV; de Sá MF; Paulo LJ; Martins WP; Ferriani RA
    Maturitas; 2009 Mar; 62(3):311-6. PubMed ID: 19193505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.